Hangzhou IECHO Science & Technology Co. Ltd. A (688092) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Hangzhou IECHO Science & Technology Co. Ltd. A ¥25.11, price ¥22.90, upside +9.7%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Hangzhou IECHO Science & Technology Co. Ltd. A for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ¥14.61 – ¥32.45 · fair‑value band ¥18.84 – ¥31.41 · the ¥22.90 price screens below the ¥25.11 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Hangzhou IECHO Science & Technology Co. Ltd. A in your weekly email
Every Wednesday you see whether Hangzhou IECHO Science & Technology Co. Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hangzhou IECHO Science&Technology Co., Ltd. manufactures and sells intelligent cutting CNC industrial software systems in China. The company offers knife cutting, laser cutting, and die cutting machine.
Show more
Hangzhou IECHO Science&Technology Co., Ltd. manufactures and sells intelligent cutting CNC industrial software systems in China. The company offers knife cutting, laser cutting, and die cutting machine. It also offers IBrightCut, a cutting software for the advertising sector; IMulCut, a Multi-layer cutting machine for garment and furniture industries; and IPlyCut, a cutting software used for interior, furniture, textile, and garment sectors. The company was founded in 1994 and is based in Hangzhou, China.
Stock analysis
Hangzhou IECHO Science & Technology Co. Ltd. A (688092) currently trades at ¥22.90, while our model-based Fair Value estimate is ¥25.11, implying the stock looks roughly 8.8% fairly valued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ¥16.17 per share, and 0 of the 26 models we run sit above the ¥22.90 price.
Bear case: the Dividend Discount group reads lowest at ¥3.16, and 26 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: ¥18.84 (bear) to ¥31.41 (bull), the price of ¥22.90 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Hangzhou IECHO Science & Technology Co. Ltd. A reported revenue of 450M CNY in FY2025 versus 319M CNY in FY2021, a compound +9.0%/yr. Reported net income was 50.9M CNY in FY2025, compounding −1.1%/yr from FY2021.
Key figures
Market cap 1.9B CNY (≈ $281M) · P/E ratio 40.9 · P/S ratio 4.63 · EPS (TTM) ¥0.5600 · Dividend yield 1.2% · Net margin 11.3% · Return on equity 7.1% · Return on assets (EBIT) 9.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −28% fair-value upside, at 10%, 688092 screens cheaper than that median.
Fair Value models
Bear ¥18.84Fair Value ¥25.11Bull ¥31.41
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.2129 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.89/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−0.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.1%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−1.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.0%
Dividend (yield on the price)1.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.24% → 13%
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+18.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +16.1% a year for the price.
Compare Hangzhou IECHO Science & Technology Co. Ltd. A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electrical Equipment & Parts · 553 stocks
Beats the industry median on 8/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score67 · Top 25%
Fair Value upside+10% · Top 25%
Profitability
Return on equity (TTM)7% · Above median
Return on assets4% · Above median
Net margin (TTM)10% · Above median
Operating margin (TTM)10% · Above median
Growth and dividend
Revenue growth3% · Below median
Dividend yield (TTM)1.2% · Above median
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Electrical Equipment & Parts median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Hangzhou IECHO Science & Technology Co. Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/688092
Frequently asked questions
Is Hangzhou IECHO Science & Technology Co. Ltd. A (688092) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥25.11 versus a price of ¥22.90, about +10% upside (fairly valued).
What is the fair value of 688092?
Our model-based fair value for Hangzhou IECHO Science & Technology Co. Ltd. A is ¥25.11 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥22.90.
What is the quality score of 688092?
Hangzhou IECHO Science & Technology Co. Ltd. A has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
Our model-based price target is the fair value of ¥25.11 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario ¥18.84, optimistic scenario ¥31.41. It is a calculation from audited fundamentals, not an analyst target.
What is the Hangzhou IECHO Science & Technology Co. Ltd. A stock forecast for 2026?
Our models put fair value at ¥25.11, about +10% upside versus a price of ¥22.90 (fairly valued). Cautious scenario ¥18.84, optimistic scenario ¥31.41. The calculation is refreshed regularly with new filings.
What is the revenue of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
Hangzhou IECHO Science & Technology Co. Ltd. A reported trailing-twelve-month revenue of about 451M CNY (latest available figure, as of Sep 24, 2026).
Does Hangzhou IECHO Science & Technology Co. Ltd. A pay a dividend?
Hangzhou IECHO Science & Technology Co. Ltd. A currently shows a dividend yield of about 1.18% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
For today's price to be fair in a discounted-cash-flow model, Hangzhou IECHO Science & Technology Co. Ltd. A would have to grow free cash flow by +18.0 % per year for five years (discount rate 12.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.1 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 688092 use?
Our models discount Hangzhou IECHO Science & Technology Co. Ltd. A at 12.0 %: a base by market capitalisation (micro), damped by beta 0.57, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Hangzhou IECHO Science & Technology Co. Ltd. A that is +18.0 % per year a year over ten years, using the same discount rate (12.0 %) and the same formula as our fair value.
How much growth has Hangzhou IECHO Science & Technology Co. Ltd. A (688092) delivered so far?
Over the past 5 years revenue at Hangzhou IECHO Science & Technology Co. Ltd. A grew +15.1 % a year. The price currently implies +18.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Hangzhou IECHO Science & Technology Co. Ltd. A (688092) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Hangzhou IECHO Science & Technology Co. Ltd. A (+18.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The free-cash-flow yield on the price is 3.49 %: that much free cash flow Hangzhou IECHO Science & Technology Co. Ltd. A produces per unit of market value. When it exceeds the discount rate of our models (12.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hangzhou IECHO Science & Technology Co. Ltd. A it is ¥25.11 per share (as of Sep 24, 2026), against a price of ¥22.90. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Hangzhou IECHO Science & Technology Co. Ltd. A stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 688092 trades below its calculated fair value: price ¥22.90, fair value ¥25.11, a gap of about +10% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 688092?
No. The price is what the market pays today (¥22.90); the fair value is what the company's own numbers justify (¥25.11). For Hangzhou IECHO Science & Technology Co. Ltd. A the two are ¥2.21 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hangzhou IECHO Science & Technology Co. Ltd. A worth?
The market values Hangzhou IECHO Science & Technology Co. Ltd. A at about 1.9B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥22.90; our models calculate a fair value of ¥25.11 per share.
What do the bullish and bearish scenarios say about 688092?
Our models span a range for Hangzhou IECHO Science & Technology Co. Ltd. A: cautious scenario ¥18.84, base ¥25.11, optimistic ¥31.41 per share (as of Sep 24, 2026, price ¥22.90). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 688092?
Hangzhou IECHO Science & Technology Co. Ltd. A trades at a price-to-earnings ratio of 40.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥25.11 is built from several models across several years. Other multiples: P/B 2.9, P/S 4.2, EV/EBITDA 26.0.
How solid is the balance sheet of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
Balance-sheet figures for Hangzhou IECHO Science & Technology Co. Ltd. A (as of Sep 24, 2026): return on equity 7.1%, debt of 0.00 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is 688092 from its 52-week high?
Hangzhou IECHO Science & Technology Co. Ltd. A trades at ¥22.90, about 28% below its 52-week high of ¥31.99 and 18% above the low of ¥19.39 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of ¥25.11 is for.
Which stocks are comparable to Hangzhou IECHO Science & Technology Co. Ltd. A?
From the same area (Industrials) we also value Contemporary Amperex Technology Co, ABB Ltd, Vertiv Holdings, Prysmian S.p.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hangzhou IECHO Science & Technology Co. Ltd. A stock attractive at the current price?
The data as of Sep 24, 2026: price ¥22.90, calculated fair value ¥25.11 (+10%), Quality Score 67/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 688092 calculated?
We run Hangzhou IECHO Science & Technology Co. Ltd. A through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥25.11, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Hangzhou IECHO Science & Technology Co. Ltd. A currently trades 10 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The closing price on Sep 24, 2026 was ¥22.90. Our model-based fair value is ¥25.11, about +10% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hangzhou IECHO Science & Technology Co. Ltd. A right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Hangzhou IECHO Science & Technology Co. Ltd. A
How large is the market capitalisation of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The market capitalisation of Hangzhou IECHO Science & Technology Co. Ltd. A is 1.9B CNY (≈ $281M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The price-to-sales ratio of Hangzhou IECHO Science & Technology Co. Ltd. A is 4.63 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
Earnings per share at Hangzhou IECHO Science & Technology Co. Ltd. A are ¥0.5600 (price ÷ EPS = P/E 40.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The dividend yield of Hangzhou IECHO Science & Technology Co. Ltd. A is 1.2% (payout 48.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The net margin of Hangzhou IECHO Science & Technology Co. Ltd. A is 11.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The return on equity (ROE) of Hangzhou IECHO Science & Technology Co. Ltd. A is 7.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
On an EBIT basis the return on assets of Hangzhou IECHO Science & Technology Co. Ltd. A is 9.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
The operating margin of Hangzhou IECHO Science & Technology Co. Ltd. A is 10.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
Revenue at Hangzhou IECHO Science & Technology Co. Ltd. A is growing +2.8% versus a year earlier (3y avg +14.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hangzhou IECHO Science & Technology Co. Ltd. A (688092)?
Earnings per share at Hangzhou IECHO Science & Technology Co. Ltd. A are growing −41.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Hangzhou IECHO Science & Technology Co. Ltd. A (688092) hold?
Hangzhou IECHO Science & Technology Co. Ltd. A holds more cash than debt, 298M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Hangzhou IECHO Science & Technology Co. Ltd. A in the live analysis
One click puts Hangzhou IECHO Science & Technology Co. Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
